Jeffrey N. Hemenway

3 Patents

• USRE0504972025

  (n-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide

  Glaxosmithkline LLC

  0 cites
• US121026252024

  Solid Forms of FXR Agonists

  Gilead Sciences, Inc.

  0 cites
• USRE0494452023

  N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide

  Sierra Oncology, Inc.

  0 cites